Skip to main content

Events

Make a Booking - Getting to the heart of it: Improving cardiovascular and renal outcomes in people with CKD and T2D

Make a Booking

This promotional webinar has been developed and funded by the Boehringer Ingelheim & Lilly Alliance and is intended for Healthcare Professionals (HCPs) in the UK and Republic of Ireland only. Promotional information regarding Alliance products will be discussed in this webinar.

Prescribing information for Jardiance® (empagliflozin) for Great Britain Healthcare Professionals is available here

Prescribing information for Jardiance® (empagliflozin) for Northern Ireland Healthcare Professionals is available here

Prescribing information for Jardiance® (empagliflozin) for Healthcare Professionals in the Republic of Ireland is available here

Adverse event reporting information can be found at the bottom of this page.

 

Account Required

You need a PCCS membership or event account to continue with your registration.

If you are already a PCCS member, or have previously created an account for registration purposes, please log in to your account:
Log in to register

Haven't got an account? Sign up to register:
Sign up for new account

You will be automatically returned to this booking process once you have logged in or created an account.

 

 

This promotional webinar has been developed and funded by the Boehringer Ingelheim & Lilly Alliance and is intended for Healthcare Professionals (HCPs) in the UK and Republic of Ireland only. Promotional information regarding Alliance products will be discussed in this webinar.

Adverse events should be reported. Reporting forms and information can be found at:

https://yellowcard.mhra.gov.uk/ (UK) and https://www.hpra.ie/homepage/about-us/report-an-issue  (Ireland). Adverse events should also be reported to Boehringer lngelheim Drug Safety on 0800 3281627 (freephone) (UK) or 012913960 (Ireland), Fax: +441344 742661 or by e-mail: PV_local_UK_lreland@boehringer-ingelheim.com  (Ireland).

PC-GB-109066 | October 2023